Table 1.
Mean | Jackknife Std. Err. | (95% CI) | |
---|---|---|---|
Age of the female population in the EA (years) | 30.2 | 0.02 | (30.2–30.3) |
Age of the male population in the EA (years) | 30.0 | 0.03 | (30.0–30.1) |
Number of survey adult participants in the EA | 43 | 0.55 | (42–44) |
Proportion of adults ever tested for HIV in the EA | 74.5% | 0.3% | (74.0–75.0) |
HIV prevalence in the EA | 13.1% | 0.2% | (12.7–13.5) |
Proportion of PLHIV aware of their HIV status | 74.9% | 0.6% | (73.7–76.1) |
Proportion of PLHIV currently on ART | 66.5% | 0.7% | (65.2–67.9) |
Prevalence of virologic suppression (VL< 1000 copies/mL) | 58.7% | 0.7% | (57.3–60.0) |
Prevalence of viremia with VL≥ 1000 copies/mL | 38.2% | 0.7% | (36.9–39.6) |
Prevalence of viremia with VL≥ 400 copies/mL | 40.2% | 0.7% | (38.8–41.6) |
Prevalence of viremia with VL≥ 40 copies/mL | 46.3% | 0.7% | (44.8–47.7) |
Note:
ART: antiretroviral therapy
EA: Enumeration area
PLHIV: People living with HIV
VL: Viral load